Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 51 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Cadaveric Clear all

Conditions: Neurotrophic Corneal Ulcer, Neurotrophic Keratitis, Cranial Nerve V Diseases
Interventions: Corneal neurotization; Procedure
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Ischemia Reperfusion Injury
Interventions: recombinant P-selectin glycoprotein ligand Ig fusion protein, Viaspan® and saline; Drug
Lead sponsor: Y's Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Liver Transplant; Complications, Perioperative/Postoperative Complications
Interventions: Cadaveric, Living Donor; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Cervical Myelopathy, Radiculopathy
Interventions: locally harvested autograft, demineralized bone matrix, and cadaveric allograft, Bone Marrow Aspirate; Biological
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Hyponatremia
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Degenerative Disc Disease, Disc Degeneration, Lumbar Discogenic Pain
Interventions: VIA Disc NP, Sham; Other
Lead sponsor: VIVEX Biologics, Inc.; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 19
States / cities: Napa, California • Santa Monica, California • Thornton, Colorado + 16 more

Conditions: Diabetes Mellitus
Interventions: human cadaveric islet cell transplantation; Procedure
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Graft Pancreatitis
Interventions: Two-Layer Method pancreas preservation system drug, Two-Layer Method pancreas preservation system device; Drug · Device
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 65 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Thermal Injury, Deep Partial-Thickness Burn, Full-Thickness Burn
Interventions: Autologous Engineered Skin Substitute, Split-Thickness Autograft (AG); Drug
Lead sponsor: Amarantus BioScience Holdings, Inc.; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 3
States / cities: Pheonix, Arizona • Houston, Texas • Seattle, Washington

Conditions: Liver Transplant
Interventions: Not listed
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Surgical Wound, Trauma Wound, Autografts, Partial-thickness Burn, Partial Thickness Wounds
Interventions: PermeaDerm Biosynthetic Wound Matrix, Frozen Human Cadaveric Allograft (FHCA); Device
Lead sponsor: Avita Medical; Industry
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 13
States / cities: Phoenix, Arizona • Washington D.C., District of Columbia • Atlanta, Georgia + 10 more

Conditions: Intestinal Transplantation
Interventions: Cell Therapy; Biological
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Delayed Graft Function
Interventions: YSPSL; Drug
Lead sponsor: Y's Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 10
States / cities: Los Angeles, California • San Francisco, California • Tampa, Florida + 7 more

Conditions: Islet Cell Transplantation, Type 1 Diabetes
Interventions: Islet cell transplantation; Biological
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2017
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Kidney Failure, Chronic
Interventions: Deceased donor nephrectomy, prior to cross clamp of donor aorta, Deceased donor nephrectomy, standard of care; Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Islet Transplantation
Interventions: Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived Vertebral Bone Marrow; Biological
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1
Interventions: Islets of Langerhans; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Bladder Carcinoma, Hernia
Interventions: Acellular Cadaveric Dermal Matrix; Other
Lead sponsor: University of Southern California; Other
Eligibility: Not listed
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Dry Eye Syndromes, Dry Eye, Ocular Inflammation, Ocular Surface Disease, Ocular Discomfort, Blepharitis
Interventions: Corneal Epithelial Stem Cell Transplant; Other
Lead sponsor: Sloan W. Rush, MD; Other
Eligibility: 18 Years to 100 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Amarillo, Texas

Conditions: Peripheral Vascular Diseases
Interventions: Not listed
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Liver Transplant; Complications
Interventions: Spy Glass DS; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: New York, New York • Pittsburgh, Pennsylvania

Conditions: Liver Diseases
Interventions: YSPSL, Placebo; Drug
Lead sponsor: Y's Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Type 1 Diabetes Mellitus, Hypoglycemia
Interventions: Allogeneic Islets of Langerhans, Everolimus, anti-thymocyte globulin, Cyclosporine; Biological · Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Burns
Interventions: NovoSorb BTM, Standard of Care; Device · Procedure
Lead sponsor: PolyNovo Biomaterials Pty Ltd.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 23
States / cities: Phoenix, Arizona • Los Angeles, California • Sacramento, California + 19 more

Search by objective public record fields.

Corneal Neurotization as a Treatment for Neurotrophic Keratopathy

YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation

Impact of Age and BMI on Liver Transplant Outcomes

Bone Marrow Aspirate Concentration in Posterior Cervical Fusion

Post Operative Hyponatremia in the Renal Transplant Population

Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease

Modification of the "Edmonton Protocol" to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the "Edmonton Protocol" to Kidney Transplant Recipients

Two-Layer Method Preservation and Resuscitation of the Cadaveric Pancreas Before Transplantation

Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds

Serum Markers of Ischemia Reperfusion Injury in Liver Transplant Patients

Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical Wounds

Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation

YSPSL for Prevention of Delayed Graft Function Part A

Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

Novel Strategies for Innovating Deceased Donor Procurement

Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy

Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus

PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)

Corneal Epithelial Stem Cells and Dry Eye Disease

MRI Guided Management of Occlusive Peripheral Arterial Disease

POCS in Liver Transplantation Patients

YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation

Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation

Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns